Evidence map›Paper›PMID 30916201›Full record

SynthesisArquivos brasileiros de cardiologia2019

Comparison of Biological and Mechanical Prostheses for Heart Valve Surgery: A Systematic Review of Randomized Controlled Trials.

Alberto Takeshi Kiyose, Erica Aranha Suzumura, Lígia Laranjeira, Anna Maria Buehler, José Amalth Espírito Santo, Otavio Berwanger, Antonio Carlos de Camargo Carvalho, Angelo Amato de Paola, Valdir Ambrósio Moises, Alexandre Biasi Cavalcanti

Open access · diamondAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Arquivos brasileiros de cardiologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. How to Choose the Right Valve Prosthesis for My Patient?Arquivos brasileiros de cardiologia · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alberto Takeshi KiyoseUniversidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brazil.ORCID 0000-0002-0827-9021
Erica Aranha SuzumuraHospital do Coração (HCOR), São Paulo, SP - Brazil.
Lígia LaranjeiraHospital do Coração (HCOR), São Paulo, SP - Brazil.
Anna Maria BuehlerHospital do Coração (HCOR), São Paulo, SP - Brazil.
José Amalth Espírito SantoHospital do Coração (HCOR), São Paulo, SP - Brazil.
Otavio BerwangerHospital do Coração (HCOR), São Paulo, SP - Brazil.
Antonio Carlos de Camargo CarvalhoUniversidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brazil.
Angelo Amato de PaolaUniversidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brazil.
Valdir Ambrósio MoisesUniversidade Federal de São Paulo (UNIFESP), São Paulo, SP - Brazil.
Alexandre Biasi CavalcantiHospital do Coração (HCOR), São Paulo, SP - Brazil.
Hospital do Coração · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe choice of a mechanical (MP) or biological prosthesis (BP) for patients with valvular heart disease undergoing replacement is still not a consensus.

objectiveWe aimed to determine the clinical outcomes of MP or BP placement in those patients.

methodsWe conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) that compared biological prostheses and mechanical prostheses in patients with valvular heart diseases and assessed the outcomes. RCTs were searched in the MEDLINE, EMBASE, LILACS, CENTRAL, SCOPUS and Web of Science (from inception to November 2014) databases. Meta-analyses were performed using inverse variance with random effects models. The GRADE system was used to rate the quality of the evidence. A P-value lower than 0.05 was considered significant.

resultsA total of four RCTs were included in the meta-analyses (1,528 patients) with follow up ranging from 2 to 20 years. Three used old generation mechanical and biological prostheses, and one used contemporary prostheses. No significant difference in mortality was found between BP and MP patients (risk ratio (RR = 1.07; 95% CI 0.99-1.15). The risk of bleeding was significantly lower in BP patients than MP patients (RR = 0.64; 95% CI 0.52-0.78); however, reoperations were significantly more frequent in BP patients (RR = 3.60; 95% CI 2.44-5.32). There were no statistically significant differences between BP and MP patients with respect to systemic arterial embolisms and infective endocarditis (RR = 0.93; 95% CI 0.66-1.31, RR = 1.21; CI95% 0.78-1.88, respectively). Results in the trials with modern and old prostheses were similar.

conclusionsThe mortality rate and the risk of thromboembolic events and endocarditis were similar between BP and MP patients. The risk of bleeding was approximately one third lower for BP patients than for MP patients, while the risk of reoperations was more than three times higher for BP patients.

Indexed as

BioprosthesisEvidence-Based MedicineHeart Valve DiseasesHeart Valve ProsthesisHeart Valve Prosthesis ImplantationHumansRandomized Controlled Trials as TopicReoperationTreatment Outcome

Identifiers

PMID30916201
PMCPMC6424027
OpenAlexW2904942386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.